CIK 0001834105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IMPACT BIOMEDICAL INC.
Sign in to watch- Ticker
- IBO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 853926944
- Phone
- 585 232 1500
- Business address
- 275 WIREGRASS PKWY,, WEST HENRIETTA, NY, 14586
- PRE 14C Other PRE 14C
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale 10% owner sold 161,000 shares at an average $0.55 ($88,006)
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 890,800 shares at $0.95 ($845,013)
- 4 Insider Changes in Ownership
- 4 Open-market sale Director sold 1,689,693 shares at an average $0.66 ($1,122,920)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 2,526,918 shares at an average $1.15 ($2,912,821)
- 4 Open-market sale 10% owner sold 605,620 shares at an average $3.22 ($1,950,928)
- 10-K Report Annual Report
- 8-K Event Material agreement
- 4 Open-market sale 10% owner sold 53,300 shares at an average $4.68 ($249,408)
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
Page 3 of 8 · 156 filings